Bernstein SocGen Group Upgrades Beam Therapeutics Inc (BEAM) to Outperform
Tweet
Share
E-mailGet Alerts BEAM Hot Sheet
Price: $26.33 -4.36%
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 18 | New: 50
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 18 | New: 50
Join SI Premium – FREE
Bernstein SocGen Group analyst William Pickering upgraded Beam Therapeutics Inc (NASDAQ: BEAM) from Market Perform to Outperform with a price target of $37.00 (from $35.00).
For an analyst ratings summary and ratings history on Beam Therapeutics Inc click here. For more ratings news on Beam Therapeutics Inc click here.
Shares of Beam Therapeutics Inc closed at $26.36 yesterday.
You May Also Be Interested In
- Evercore ISI upgrades U.S. Bancorp to Outperform with $72 target, 'Party like it's 1999'
- UnitedHealth Group (UNH) PT Raised to $512 at BofA Securities
- Rockpoint Gas Storage (RGSI:CN) PT Lowered to Cdn$33 at CIBC
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
